Physician profile
David L Brenner
NPI 1790878304
$1,640.14
in general payments reported to CMS, 2019-2025
18 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $371 · 2022: $589 · 2023: $350 · 2024: $191 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.85 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $324.61 | 2021-2023 | |
| Vanda Pharmaceuticals INC. | $235.73 | 2022-2025 | Hetlioz, Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $211.45 | 2022 | |
| Janssen Pharmaceuticals, INC | $166.76 | 2021-2025 | Spravato |
| Alkermes, INC. | $128.47 | 2021-2023 | Vivitrol |
| Neurocrine Biosciences, INC. | $99.44 | 2021-2025 | Ingrezza |
| Lundbeck LLC | $89.79 | 2022-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $69.68 | 2023-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Supernus Pharmaceuticals, INC. | $65.98 | 2022 | |
| Axsome Therapeutics, INC. | $57.50 | 2023 | Auvelity |
| Sunovion Pharmaceuticals INC. | $42.26 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.95 | 2022-2023 | Trintellix |
| Novo Nordisk INC | $28.11 | 2024 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 2024 | Cobenfy |
| Merck Sharp & Dohme LLC | $25.53 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $15.84 | 2023 | Aplenzin |
| Eisai INC. | $11.60 | 2021 | |
| Corium, LLC | $5.17 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.